Work

Supplementary Data from Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV− and HPV+ Head and Neck Cancers to TNFα, TRAIL, and Radiation Therapy

Year: 2023
Type: supplementary-materials
Abstract: Tables S1-3 and Figures S1-S8
Language: English
Open Access status: gold
OpenAlex ID: W4361934860
Cites:
Cited by:
Related to: 10